Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Accumulated Expenses: 2014-2018

Historic Accumulated Expenses for Armata Pharmaceuticals (ARMP) over the last 4 years, with Sep 2018 value amounting to $1.8 million.

  • Armata Pharmaceuticals' Accumulated Expenses rose 52.93% to $1.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.8 million, marking a year-over-year increase of 52.93%. This contributed to the annual value of $1.1 million for FY2017, which is 17.32% up from last year.
  • As of Q3 2018, Armata Pharmaceuticals' Accumulated Expenses stood at $1.8 million, which was up 28.09% from $1.4 million recorded in Q2 2018.
  • Armata Pharmaceuticals' Accumulated Expenses' 5-year high stood at $1.8 million during Q3 2018, with a 5-year trough of $10,000 in Q3 2016.
  • Over the past 3 years, Armata Pharmaceuticals' median Accumulated Expenses value was $965,000 (recorded in 2018), while the average stood at $849,909.
  • In the last 5 years, Armata Pharmaceuticals' Accumulated Expenses slumped by 97.96% in 2016 and then spiked by 11,350.00% in 2017.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Accumulated Expenses stood at $457,000 in 2014, then surged by 59.30% to $728,000 in 2015, then increased by 22.94% to $895,000 in 2016, then climbed by 17.32% to $1.1 million in 2017, then soared by 52.93% to $1.8 million in 2018.
  • Its Accumulated Expenses stands at $1.8 million for Q3 2018, versus $1.4 million for Q2 2018 and $965,000 for Q1 2018.